Ask Warren

Xcell Therapeutics

373110 · KOSDAQ · ₩373110 · 엑셀세라퓨틱스

₩973▼ ₩25 (2.51%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

202520242023
Revenue₩1.9B₩1.9B₩1.1B
Cost of sales₩3.9B₩3.3B₩3B
Gross profit−₩2B−₩1.4B−₩1.9B
Operating income−₩11B−₩9.3B−₩8.7B
Net income−₩11B−₩9.5B−₩9.3B
Net income to shareholders−₩11B−₩9.5B−₩9.3B

Balance sheet

202520242023
Total assets₩16B₩17B₩10B
Current assets₩9.6B₩11B₩4.4B
Cash and equivalents₩2.1B₩7.8B₩1.2B
Total liabilities₩8.6B₩7.8B₩8.1B
Current liabilities₩5.3B₩4.9B₩5.4B
Borrowings₩4.6B₩4.7B₩5.2B
Total equity₩7.1B₩9.1B₩2.4B
Shareholders' equity₩7.1B₩9.1B₩2.4B

Cash flow

202520242023
Cash from operations−₩9.5B−₩7B−₩6.8B
Capital spending₩867M₩383M₩225M
Free cash flow−₩10B−₩7.4B−₩7B

Consolidated where available. Amounts in won.

Also known as: Xcell Therapeutics / 엑셀세라퓨틱스 / 373110 / KRX:373110

Source: KRX statistical information